256 related articles for article (PubMed ID: 28176230)
1. Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.
Sarkar S; Alam MM; Das G; Datta S
Indian J Pediatr; 2017 May; 84(5):349-356. PubMed ID: 28176230
[TBL] [Abstract][Full Text] [Related]
2. The correlation between the Childhood Health Assessment Questionnaire and disease activity in juvenile idiopathic arthritis.
Sontichai W; Vilaiyuk S
Musculoskeletal Care; 2018 Sep; 16(3):339-344. PubMed ID: 29573557
[TBL] [Abstract][Full Text] [Related]
3. Using the Juvenile Arthritis Disease Activity Score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register.
Mourão AF; Santos MJ; Melo-Gomes J; Martins FM; Costa JA; Ramos F; Brito I; Duarte C; Figueira R; Figueiredo G; Furtado C; Lopes A; Oliveira M; Rodrigues A; Salgado M; Sousa M; Branco JC; Fonseca JE; Canhão H
Arthritis Care Res (Hoboken); 2014 Apr; 66(4):585-91. PubMed ID: 25354266
[TBL] [Abstract][Full Text] [Related]
4. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
Gilliam BE; Chauhan AK; Low JM; Moore TL
Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
[TBL] [Abstract][Full Text] [Related]
5. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
Oen K; Tucker L; Huber AM; Miettunen P; Scuccimarri R; Campillo S; Cabral DA; Feldman BM; Tse S; Chédeville G; Spiegel L; Schneider R; Lang B; Ellsworth J; Ramsey S; Dancey P; Silverman E; Chetaille AL; Cameron B; Johnson N; Dorval J; Petty RE; Duffy KW; Boire G; Haddad E; Houghton K; Saint-Cyr C; Turvey SE; Benseler S; Cheang M; Yeung RS; Duffy CM
Arthritis Rheum; 2009 Aug; 61(8):1077-86. PubMed ID: 19644903
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis.
Kamiya Y; Kawada J; Kawano Y; Torii Y; Kawabe S; Iwata N; Ito Y
Clin Rheumatol; 2015 Oct; 34(10):1705-12. PubMed ID: 25846830
[TBL] [Abstract][Full Text] [Related]
7. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
8. High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
Alberdi-Saugstrup M; Zak M; Nielsen S; Herlin T; Nordal E; Berntson L; Fasth A; Rygg M; Klaus Müller ;
Rheumatol Int; 2017 May; 37(5):695-703. PubMed ID: 28283733
[TBL] [Abstract][Full Text] [Related]
9. Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.
Ganeva M; Fuehner S; Kessel C; Klotsche J; Niewerth M; Minden K; Foell D; Hinze CH; Wittkowski H
Pediatr Rheumatol Online J; 2021 May; 19(1):64. PubMed ID: 33933108
[TBL] [Abstract][Full Text] [Related]
10. Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
Shady MM; Fathy HA; Ali A; Youness ER; Fathy GA
J Pediatr (Rio J); 2015; 91(4):352-7. PubMed ID: 25727025
[TBL] [Abstract][Full Text] [Related]
11. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
12. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
[TBL] [Abstract][Full Text] [Related]
13. Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis - 265 cases from a Turkish center.
Çakan M; Aktay-Ayaz N; Keskindemirci G; Ekinci DY; Karadağ ŞG
Turk J Pediatr; 2017; 59(5):548-554. PubMed ID: 29745116
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience.
Demir S; Sönmez HE; Arslanoğlu-Aydın E; Özen S; Bilginer Y
Turk J Pediatr; 2019; 61(2):180-185. PubMed ID: 31951328
[TBL] [Abstract][Full Text] [Related]
15. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.
Nordal EB; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Peltoniemi S; Straume B; Rygg M
Ann Rheum Dis; 2012 Jul; 71(7):1122-7. PubMed ID: 22258487
[TBL] [Abstract][Full Text] [Related]
16. Decreased frequency of allergy in juvenile idiopathic arthritis: Results of a case-control study.
Avar-Aydin PO; Nepesov S; Barut K; Sahin S; Adrovic A; Cokugras HC; Kasapcopur O
Mod Rheumatol; 2021 May; 31(3):697-703. PubMed ID: 32815440
[TBL] [Abstract][Full Text] [Related]
17. Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease.
Mizuta M; Shimizu M; Inoue N; Kasai K; Nakagishi Y; Takahara T; Hamahira K; Yachie A
Mod Rheumatol; 2016 Nov; 26(6):929-932. PubMed ID: 27433933
[TBL] [Abstract][Full Text] [Related]
18. Utilizing ultrasound findings of a single indicator joint to assess non-systemic juvenile idiopathic arthritis.
Huang YH; Hu YC; Liao CH; Chiang BL; Lu CH; Li KJ; Yang YH
Pediatr Rheumatol Online J; 2021 Apr; 19(1):60. PubMed ID: 33926518
[TBL] [Abstract][Full Text] [Related]
19. Haptoglobin in Juvenile Idiopathic Arthritis.
Berntson L; Palm J; Axling F; Zarelius P; Hellström PM; Webb DL
Pediatr Rheumatol Online J; 2022 Dec; 20(1):117. PubMed ID: 36517828
[TBL] [Abstract][Full Text] [Related]
20. Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or polyarthritis.
Kotaniemi K; Kotaniemi A; Savolainen A
Clin Exp Rheumatol; 2002; 20(1):109-12. PubMed ID: 11892693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
